The Washington Biotechnology & Biomedical Association is organizing an event on some of the best practices to follow in the notoriously difficult field of new drug development. David Brewster of Roche, Roger Ulrich of Calistoga Pharmaceuticals, Richard Slauter of MPI Research, and Jerry Moore of Pacific BioDevelopment will be part of the panel discussion. For more information on how to register, click here.